Normally, skin cells take about a month to form and rise to the surface. In people with psoriasis, this process happens in ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

Psoriasis is a chronic autoimmune condition that mainly affects the skin. When you have psoriasis, your immune system sends ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...

How to tell if you have psoriasis or ringworm as these two skin conditions look similar but need completely different ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

A new study published in the Journal of American Medical Association showed that Guselkumab was highly effective and durable ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

Autoimmune diseases like lupus rheumatoid arthritis and psoriasis don’t just affect joints or skin they can silently damage ...

Low testosterone and limited sleep emerged as key, independent contributors to psoriasis risk, revealing modifiable targets ...